PharmaSeq

Home Company News & Events Press Releases 2011 National Cancer Institute Funds Biorepository Project at PharmaSeq with a Fast Track SBIR Award

Press Releases

National Cancer Institute Funds Biorepository Project at PharmaSeq with a Fast Track SBIR Award

Monmouth Junction, NJ, October 09, 2011. PharmaSeq, Inc., announced today the receipt of a Fast Track Small Business Innovative Research (SBIR) grant for a project entitled "Light-activated Electronic p-Chips for Tagging Samples in Biorepositories and Cryostorage". The grant was awarded by the National Cancer Institute of the NIH.

The specific aims of the grant are to develop and validate an improved system for tagging and tracking sample vials that used in biorepositories using PharmaSeq's patented p-Chips as the identification tag. Each year, millions of samples are stored in the nation's 179 major biorepositories many of which are retrieved for important life science or medical research. The samples, which are stored either in low temperature freezers or liquid nitrogen, are often difficult to locate and retrieve due to limitations of current tagging methods. The p-Chips, which are very small and inexpensive, serve as electronic tags that are functional at very low temperatures; and can easily be located using a specially designed reader, both of which are designed and build by PharmaSeq. The system being developed under this grant will be able to read multiple vials at the same time and, therefore, not subject samples to partial thawing when being identified. It is expected that wide spread implementation of the new system will lead to significant cost savings for both the specimen contributors and the operators of the biorepositories, and to provide for the first time improve chain-of-custody for the overall system of sample storage.

Dr. Wlodek Mandecki, President of PharmaSeq, Inc., said: "This grant award emphasizes the wide utility of PharmaSeq p-Chips in multiple applications in the biomedical laboratory. The grant will allow PharmaSeq to develop a line of products streamlining operations in biorepositories, in particular, p-Chip- tagged vials, photonic ID readers for the vials, and an array reader for racks of tubes. Widespread deployment of p-Chip-based storage systems will contribute to lower operating costs and better efficiency in life science research."

For further information, please contact Dr. Richard Morris, CEO, or Dr. Wlodek Mandecki, President, at (732) 355-0100 ext 11.

PharmaSeq, Inc.
11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852


Find us on the web at: www.pharmaseq.com.


Home Company News & Events Press Releases 2011 National Cancer Institute Funds Biorepository Project at PharmaSeq with a Fast Track SBIR Award